This was significant to us, as loss-of-function mutations in DNMT3A are leading drivers of clonal hematopoiesis of indeterminate potential (CHIP), a highly inflammatory condition common in the elderly, and are strongly associated with lung cancer risk (72). This evidence concerns the gene DNMT3A and lung carcinoma.